On the other hand, elevated resistin concentration is involved in the pathogenesis of inflammation and the development of insulin resistance, type 2 diabetes, hypertension, atherogenic dyslipidemia and atherosclerosis [11]. This evidence concerns the gene RETN and metabolic syndrome.